Michael McConnell, MD
Plastic and Reconstructive Surgery · Fullerton, CANPI 1629117320
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 52.5% of the total. Reporting peaked in 2019 at $1,035 and has fallen 74.0% since, to $269 in 2025.
Across 133 payments — averaging $28.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sientra, Inc.$1K
- Merz North America, Inc.$113
- Pacira Pharmaceuticals Incorporated$80
- Motiva USA, LLC$76
- Access Pro Medical, LLC$64
- plus $186 from 10 others
What the payments were for
- Food & beverage$3,844100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 90 | $2,017 |
| Sientra, Inc. | 25 | $1,308 |
| Merz North America, Inc. | 3 | $113 |
| Pacira Pharmaceuticals Incorporated | 1 | $80 |
| Motiva USA, LLC | 3 | $76 |
| Access Pro Medical, LLC | 1 | $64 |
| KCI USA, Inc. | 1 | $27 |
| Boston Scientific | 1 | $22 |
| Solventum Corporation | 1 | $22 |
| Acelrx Pharmaceuticals, Inc. | 1 | $21 |
| Sanofi | 1 | $20 |
| Merck | 1 | $19 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $17 |
| Guard Medical Inc. | 1 | $14 |
| Smith+Nephew | 1 | $14 |
| Galderma Laboratories, L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,844 in reported general payments places this provider in the 65th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 23 | $212 |
| Scopolamine | 11 | $115 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Fullerton
- Mark SuskiThousand Oaks$294K
- Corey MaasSan Francisco$286K
- Arian MowlaviLaguna Beach$250K
- Charles LeeSan Francisco$200K
- David SieberSan Francisco$195K
- David KulberLos Angeles$194K
- Matthew NykielUpland$181K
- Subhas GuptaLoma Linda$178K
- Jeffrey HammoudehLos Angeles$159K
- Geoffrey GurtnerPalo Alto$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.